DaxibotulinumtoxinA for Injection for the Treatment of Glabellar Lines: Efficacy Results From SAKURA 3, a Large, Open-Label, Phase 3 Safety Study

BACKGROUND: DaxibotulinumtoxinA for Injection (DAXI) is botulinum toxin Type A formulated with a novel peptide excipient. Two pivotal, single-treatment, placebo-controlled trials demonstrated efficacy and safety for moderate or severe glabellar lines. OBJECTIVE: To further evaluate DAXI in a large,...

Descripción completa

Detalles Bibliográficos
Autores principales: Fabi, Sabrina G., Cohen, Joel L., Green, Lawrence J., Dhawan, Sunil, Kontis, Theda C., Baumann, Leslie, Gross, Todd M., Gallagher, Conor J., Brown, Jessica, Rubio, Roman G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7752211/
https://www.ncbi.nlm.nih.gov/pubmed/32773446
http://dx.doi.org/10.1097/DSS.0000000000002531

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7752211/
https://www.ncbi.nlm.nih.gov/pubmed/32773446
http://dx.doi.org/10.1097/DSS.0000000000002531

Ejemplares similares